Clinical reviews in allergy最新文献_第8页

Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma 慢性淋巴细胞白血病和多发性骨髓瘤的免疫缺陷

Clinical reviews in allergy Pub Date : 1992-03-01 DOI: 10.1007/BF02914369

A. Winkelstein, P. S. Jordan

引用次数: 0

The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses IVIG在抗磷脂抗体和复发性妊娠丢失患者管理中的作用

Clinical reviews in allergy Pub Date : 1992-03-01 DOI: 10.1007/BF02914374

P. Ann

引用次数: 3

Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes 免疫血清球蛋白作为原发性免疫缺陷综合征患者替代疗法的临床应用

Clinical reviews in allergy Pub Date : 1992-03-01 DOI: 10.1007/BF02914366

S. Schwartz

引用次数: 1

The clinical efficacy of IVGG in Kawasaki disease IVGG治疗川崎病的临床疗效观察

Clinical reviews in allergy Pub Date : 1992-03-01 DOI: 10.1007/BF02914372

A. Rowley, Stanford T. Shuiman

引用次数: 1

Current status of intravenous immunoglobuiin in preventing or treating neonatal bacterial infections 静脉注射免疫球蛋白预防或治疗新生儿细菌感染的现状

Clinical reviews in allergy Pub Date : 1992-03-01 DOI: 10.1007/BF02914367

L. Weisman, D. Cruess, G. Fischer

引用次数: 0

IVIG in the treatment of children with acute and chronic ldiopathic thrombocytopenic purpura and the autoimmune cytopenias IVIG治疗儿童急慢性放畸性血小板减少性紫癜及自身免疫性细胞减少

Clinical reviews in allergy Pub Date : 1992-03-01 DOI: 10.1007/BF02914370

D. Nugent

引用次数: 0

The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses. IVIG在抗磷脂抗体和复发性妊娠丢失患者管理中的作用。

Clinical reviews in allergy Pub Date : 1992-02-01 DOI: 10.1007/978-1-4612-0417-6_9

A Parke

{"title":"The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses.","authors":"A Parke","doi":"10.1007/978-1-4612-0417-6_9","DOIUrl":"https://doi.org/10.1007/978-1-4612-0417-6_9","url":null,"abstract":"<p><p>Intravenous immune gamma-globulin appears to have a role in the management of some autoimmune-mediated diseases. The exact mechanisms whereby IVIG is beneficial to patients with these diseases are not understood. The antiphospholipid-antibody syndrome is a recently recognized syndrome in which antibodies to negatively charged phospholipids are associated with a thrombotic diathesis, fetal wastage, and thrombocytopenia. The association between these antibodies and the clinical complaints is unknown. Recent evidence has suggested that a cofactor, a serum protein or glycoprotein (of approx 50 kDa) is essential for so-called antiphospholipid antibodies to bind to phospholipids. It may be that variations in this cofactor and its binding are some of the factors that determine whether high levels of antiphospholipid antibodies result in pathological consequences. Patients with antiphospholipid antibodies who have experienced previous fetal losses will continue to experience fetal wastage without some form of therapeutic intervention. The optimum therapy for these patients is yet to be determined, but recent isolated anecdotal reports suggest that IVIG may be of some benefit. IVIG appears to be less toxic to the mother than prednisone. The true benefit of IVIG, however, can be determined only by randomized, well controlled trials. Adequate numbers of patients could only be obtained by multicenter studies, and these should be designed to compare anticoagulation alone with anticoagulation and IVIG. Justifying a placebo group is difficult, as it is known that greater than 90% of pregnancies in women with aPL who have previously experienced fetal wastage fail to produce a live infant. It is only by doing such studies that the true role of IVIG in the management of pregnant patients with aPL can be determined.</p>","PeriodicalId":77073,"journal":{"name":"Clinical reviews in allergy","volume":"10 1-2","pages":"105-18"},"PeriodicalIF":0.0,"publicationDate":"1992-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12773492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 26

The clinical efficacy of IVGG in Kawasaki disease. IVGG治疗川崎病的临床疗效观察。

Clinical reviews in allergy Pub Date : 1992-02-01 DOI: 10.1007/978-1-4612-0417-6_7

A H Rowley, S T Shulman

引用次数: 6

IVIG therapy today. 今天的IVIG治疗。

Clinical reviews in allergy Pub Date : 1992-02-01

引用次数: 0

IVIG therapy in neonatal isoimmune thrombocytopenic purpura and alloimmunization thrombocytopenia. 新生儿等免疫血小板减少性紫癜和同种免疫血小板减少症的IVIG治疗。

Clinical reviews in allergy Pub Date : 1992-02-01 DOI: 10.1007/978-1-4612-0417-6_6

J Kurtzberg, K P Dunsmore

引用次数: 1